A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults
Clinical trial NCT06680375 · COMPLETED
Trial details
- NCT number
- NCT06680375
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2025-06-09
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.